Seelos Therapeutics Inc (SEEL)
0.289
-0.01
(-1.73%)
USD |
NASDAQ |
May 08, 16:00
0.2889
0.00 (0.00%)
After-Hours: 04:56
Seelos Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2018 | 0.459M |
| March 31, 2018 | 0.709M |
| December 31, 2017 | 12.21M |
| September 30, 2017 | 12.00M |
| June 30, 2017 | 11.75M |
| March 31, 2017 | 11.67M |
| December 31, 2016 | 0.265M |
| September 30, 2016 | 0.146M |
| June 30, 2016 | 0.118M |
| March 31, 2016 | -0.063M |
| December 31, 2015 | -0.322M |
| September 30, 2015 | -0.286M |
| June 30, 2015 | -0.326M |
| March 31, 2015 | 0.285M |
| December 31, 2014 | 0.145M |
| September 30, 2014 | -0.004M |
| June 30, 2014 | 0.136M |
| March 31, 2014 | -0.425M |
| December 31, 2013 | 4.709M |
| September 30, 2013 | 4.596M |
| June 30, 2013 | 6.212M |
| March 31, 2013 | 6.177M |
| December 31, 2012 | 1.068M |
| September 30, 2012 | 1.952M |
| June 30, 2012 | 0.2427M |
| Date | Value |
|---|---|
| March 31, 2012 | 0.0719M |
| December 31, 2011 | 0.344M |
| September 30, 2011 | -0.2916M |
| June 30, 2011 | 0.286M |
| March 31, 2011 | -0.3625M |
| December 31, 2010 | -0.436M |
| September 30, 2010 | -0.3455M |
| June 30, 2010 | -0.9013M |
| March 31, 2010 | 0.0881M |
| December 31, 2009 | 0.3445M |
| September 30, 2009 | 0.4221M |
| June 30, 2009 | 0.4108M |
| March 31, 2009 | 0.235M |
| December 31, 2008 | 0.796M |
| September 30, 2008 | 0.9576M |
| June 30, 2008 | 2.431M |
| March 31, 2008 | 2.385M |
| December 31, 2007 | 0.1491M |
| September 30, 2007 | 0.906M |
| June 30, 2007 | -0.4665M |
| March 31, 2007 | 0.5667M |
| December 31, 2006 | -0.3978M |
| September 30, 2006 | -0.8266M |
| June 30, 2006 | -0.285M |
| March 31, 2006 | -0.5472M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| 180 Life Sciences Corp | -- |
| Acurx Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |